{
  "id": "5c71d6d27c78d6947100006a",
  "type": "factoid",
  "question": "Fecal transplantation is used to treat infection with what bacteria?",
  "ideal_answer": "Fecal microbiota transplantation is used to treat Clostridium difficile infection",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28178876",
    "http://www.ncbi.nlm.nih.gov/pubmed/27999162",
    "http://www.ncbi.nlm.nih.gov/pubmed/27194400",
    "http://www.ncbi.nlm.nih.gov/pubmed/25548572",
    "http://www.ncbi.nlm.nih.gov/pubmed/28125667",
    "http://www.ncbi.nlm.nih.gov/pubmed/29450831",
    "http://www.ncbi.nlm.nih.gov/pubmed/29020255",
    "http://www.ncbi.nlm.nih.gov/pubmed/28506071",
    "http://www.ncbi.nlm.nih.gov/pubmed/29104169",
    "http://www.ncbi.nlm.nih.gov/pubmed/26204547",
    "http://www.ncbi.nlm.nih.gov/pubmed/28195180",
    "http://www.ncbi.nlm.nih.gov/pubmed/29076071",
    "http://www.ncbi.nlm.nih.gov/pubmed/23333862",
    "http://www.ncbi.nlm.nih.gov/pubmed/24939885",
    "http://www.ncbi.nlm.nih.gov/pubmed/26616138",
    "http://www.ncbi.nlm.nih.gov/pubmed/23844515",
    "http://www.ncbi.nlm.nih.gov/pubmed/26901316",
    "http://www.ncbi.nlm.nih.gov/pubmed/24440934",
    "http://www.ncbi.nlm.nih.gov/pubmed/27648772"
  ],
  "snippets": [
    {
      "text": "Fecal microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium difficile, a common hospital-acquired infection",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28178876",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Mini-Fecal Microbiota Transplantation for Treatment of Clostridium difficile Proctitis Following Total Colectomy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29020255",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "We aimed to assess the asymptomatic Clostridium difficile carriage rates following fecal microbiota transplantation",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29104169",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria.Fecal microbiota transplantation (FMT) is becoming a more widely used technology for treatment of recurrent Clostridum difficile infection (CDI). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23333862",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Fecal transplantation, the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea, and abdominal pain. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26616138",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT) has emerged as a highly efficacious treatment for difficult cases of refractory and/or recurrent Clostridium difficile infection (CDI). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29450831",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Recently, fecal microbiota transplantation (FMT) has been applied to treat CDI. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29076071",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "While previous treatments used fresh fecal slurries as a source of microbiota for FMT, we recently reported the successful use of standardized, partially purified and frozen fecal microbiota to treat CDI. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23333862",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27999162",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Our results demonstrate that frozen fecal microbiota from a healthy donor can be used to effectively treat recurrent CDI resulting in restoration of the structure of gut microbiota and clearing of Clostridum difficile.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23333862",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fecal microbiota transplantation (FMT) is becoming a more widely used technology for treatment of recurrent Clostridum difficile infection (CDI).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23333862",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Our results demonstrate that frozen fecal microbiota from a healthy donor can be used to effectively treat recurrent CDI resulting in restoration of the structure of gut microbiota and clearing of Clostridum difficile.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23333862",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "While previous treatments used fresh fecal slurries as a source of microbiota for FMT, we recently reported the successful use of standardized, partially purified and frozen fecal microbiota to treat CDI.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23333862",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fecal transplantation, the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea, and abdominal pain.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26616138",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here we present the case of a child with SBS and recurrent, debilitating D-lactic acidosis, which was successfully treated with fecal transplantation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26616138",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recently, fecal microbiota transplantation (FMT) has been successfully used to treat recurrent C. difficile infection.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24939885",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fecal microbiota transplantation (FMT) has an incomparable efficacy to treat recurrent Clostridium difficile infection, with near 90% of success.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26204547",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fecal microbiota transplantation (FMT) has provided a successful treatment method for some patients with recurrent C. difficile infection, but its mechanism and long-term effects remain unknown.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24939885",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fecal microbiota transplantation (FMT), a highly effective treatment for recurrent Clostridium difficile infection, has emerged as a promising therapy for intestinal MDR bacterial decolonization.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27194400",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVES\nFecal microbiota transplantation (FMT) is increasingly being used for treatment of recurrent Clostridium difficile infection (R-CDI) that cannot be cured with antibiotics alone.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28195180",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND\nFecal microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile infection (CDI).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27648772",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Bacterial communities from subjects treated for recurrent Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool samples or autologous stool samples, were characterized by Illumina next-generation sequencing.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27999162",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fecal microbiota transplantation is a compelling treatment for recurrent Clostridium difficile infections, with potential applications against other diseases associated with changes in gut microbiota.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28125667",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fecal microbiota transplantation (FMT) holds considerable promise as a therapy for recurrent Clostridium difficile infection, but well-designed, randomized-controlled trials and Long-term follow-up registries are stilt required.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23844515",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile infection (CDI) and is considered as a treatment for other gastrointestinal (GI) diseases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25548572",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND Fecal microbiota microbiota transplantation from a healthy donor into an individual with CD infection (CDI) can resolve symptoms.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24440934",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fecal microbiota transplantation is relatively simple to perform, well-tolerated, safe and effective in recurrent Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic therapy failure.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28506071",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The use of fecal microbiota transplantation in recurrent Clostridium difficile infection and coexistent inflammatory bowel disease remains unclear.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28506071",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recently, fecal microbiota transplantation (FMT) has been successfully used to treat recurrent C. difficile infection.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24939885",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recently, fecal microbiota transplantation (FMT) has been successfully used to treat recurrent C. difficile infection.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24939885",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Our results demonstrate that frozen fecal microbiota from a healthy donor can be used to effectively treat recurrent CDI resulting in restoration of the structure of gut microbiota and clearing of Clostridum difficile.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23333862",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fecal transplantation by colonoscopy (or enema, if colonoscopy is unavailable) is cost-effective for treating recurrent CDI in Canada.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26901316",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Clostridium difficile"
}